PRGO
Get informed when a big investor buys or sells
+ FollowUndervalued by 21.7% based on the discounted cash flow analysis.
| Market cap | $2.30 Billion |
|---|---|
| Enterprise Value | $5.22 Billion |
| Dividend Yield | $1.16 (6.98%) |
| Earnings per Share | $-10.29 |
| Beta | 0.54 |
| Outstanding Shares | 139,100,000 |
| P/E Ratio | -1.33 |
|---|---|
| PEG | 0.13 |
| Price to Sales | 0.55 |
| Price to Book Ratio | 0.89 |
| Enterprise Value to Revenue | 1.26 |
| Enterprise Value to EBIT | -3.58 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.64 |
| Debt to Equity | 1.32 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 46.38% |
|---|---|
| Total Calls | 53,700▼ 96.69% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 2.76%▼ 114.27% |
|---|---|
| Total Invested | $56.10M▼ 96.68% |
| Investors Holding | 30▼ 322.00% |
No data
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It off...